Dashboard
Manage Tickers

CADL Candel Therapeutics, Inc.

Nasdaq candeltx.com


$ 5.09 $ -0.04 (-0.78 %)    

Wednesday, 05-Nov-2025 15:59:58 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 622.38 $ 4.94 (0.8 %)
DIA $ 473.04 $ 2.23 (0.47 %)
SPY $ 677.28 $ 2.47 (0.37 %)
TLT $ 89.01 $ -0.57 (-0.64 %)
GLD $ 365.20 $ 0.10 (0.03 %)
$ 5.09
$ 5.14
$ 4.95 x 10
$ 5.19 x 100
$ 4.98 - $ 5.14
$ 3.79 - $ 14.60
499,188
na
279.42M
$ 0.92
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-13-2025 03-31-2025 10-Q
3 03-13-2025 12-31-2024 10-K
4 11-14-2024 09-30-2024 10-Q
5 08-13-2024 06-30-2024 10-Q
6 05-14-2024 03-31-2024 10-Q
7 03-28-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-10-2023 06-30-2023 10-Q
10 05-11-2023 03-31-2023 10-Q
11 03-30-2023 12-31-2022 10-K
12 11-10-2022 09-30-2022 10-Q
13 08-05-2022 06-30-2022 10-Q
14 05-12-2022 03-31-2022 10-Q
15 03-29-2022 12-31-2021 10-K
16 11-12-2021 09-30-2021 10-Q
17 09-08-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

candel-therapeutics-to-present-data-about-solid-tumors-at-society-for-immunotherapy-of-cancer-in-maryland
Candel Therapeutics To Present Data About ...
11/04/2025 14:03:18

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company developing multimo...

stephens--co-initiates-coverage-on-candel-therapeutics-with-overweight-rating-announces-price-target-of-15
Stephens & Co. Initiates Coverage On Cande...
10/28/2025 10:12:16

Stephens & Co. analyst Sudan Loganathan initiates coverage on Candel Therapeutics (NASDAQ:CADL) with a Overweight rating...

lifesci-capital-initiates-coverage-on-candel-therapeutics-with-outperform-rating-announces-price-target-of-16
LifeSci Capital Initiates Coverage On Cand...
10/21/2025 14:52:09

LifeSci Capital initiates coverage on Candel Therapeutics (NASDAQ:CADL) with a Outperform rating and announces Price Target o...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
10/14/2025 17:06:11

Core News & Articles
Candel Therapeutics Secures $130M Loan Fac...
10/14/2025 12:14:23

$50 million drawn down at closing, with access to up to an additional $80 millionStrengthens Company's financial position; ...

candel-therapeutics-reports-glioblastoma-trial-data-as-study-reveals-can-3110-triggers-immune-driven-tumor-remodeling-in-the-journal-science-translational-medicine
Candel Therapeutics Reports Glioblastoma T...
10/14/2025 12:13:06

Candel Therapeutics, Inc. (Candel or the Company) (NASDAQ:CADL), a clinical-stage biopharmaceutical company focused on developi...

candel-therapeutics-to-present-insights-from-enlighten-discovery-platform-and-additional-data-from-can-2409-program-in-nsclc-at-sitc-annual-meeting
Candel Therapeutics To Present Insights Fr...
10/03/2025 13:11:52

hc-wainwright--co-reiterates-buy-on-candel-therapeutics-maintains-23-price-target
HC Wainwright & Co. Reiterates Buy on Cand...
09/29/2025 16:22:26

HC Wainwright & Co. analyst Andres Y. Maldonado reiterates Candel Therapeutics (NASDAQ: CADL) with a Buy and maintains $...

candel-therapeutics-announces-can-2409-significantly-improves-disease-free-survival-in-prostate-cancer-showing-benefit-across-radiation-modalities-in-phase-3-trial
Candel Therapeutics Announces CAN-2409 Sig...
09/29/2025 12:20:33

CAN-2409 improved disease-free survival in patients with intermediate-to-high-risk, localized prostate cancer compared to place...

candel-therapeutics-to-present-at-astro-2025-sept-28
Candel Therapeutics To Present At ASTRO 20...
09/17/2025 12:06:09

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
09/03/2025 17:06:07

b-of-a-securities-downgrades-candel-therapeutics-to-neutral-lowers-price-target-to-7
B of A Securities Downgrades Candel Therap...
09/03/2025 15:54:19

B of A Securities analyst Alec Stranahan downgrades Candel Therapeutics (NASDAQ:CADL) from Buy to Neutral and lowers the pri...

candel-therapeutics-files-for-mixed-shelf-of-upto-300m
Candel Therapeutics Files For Mixed Shelf ...
08/14/2025 12:43:34

- SEC Filing

candel-therapeutics-q2-eps-009-beats-017-estimate
Candel Therapeutics Q2 EPS $(0.09) Beats $...
08/14/2025 12:29:23

Candel Therapeutics (NASDAQ:CADL) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $...

candel-therapeutics-secures-ema-orphan-designation-for-can-2409-for-treatment-of-pancreatic-cancer
Candel Therapeutics Secures EMA Orphan Des...
07/24/2025 12:07:12

andel Therapeutics, Inc. (Candel or the Company) (NASDAQ:CADL), a clinical-stage biopharmaceutical company focused on developin...

asml-j-b-hunt-transport-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
ASML, J B Hunt Transport And Other Big Sto...
07/16/2025 12:28:43

candel-therapeutics-added-to-multiple-russell-value-indexes-in-2025-reconstitution
Candel Therapeutics Added To Multiple Russ...
07/09/2025 12:09:43

Candel Therapeutics, Inc. (Candel or the Company) (NASDAQ:CADL), a clinical-stage biopharmaceutical company focused on developi...

hc-wainwright--co-assumes-candel-therapeutics-at-buy-announces-price-target-of-23
HC Wainwright & Co. Assumes Candel Therape...
06/30/2025 11:09:36

HC Wainwright & Co. analyst Andrew Fein assumes Candel Therapeutics (NASDAQ:CADL) with a Buy rating and announces Price ...

candel-therapeutics-announces-15m-registered-direct-offering-of-32m-shares-at-467-per-share
Candel Therapeutics Announces $15M Registe...
06/24/2025 13:09:05

Candel Therapeutics, Inc. (Candel or the Company) (NASDAQ:CADL), a clinical-stage biopharmaceutical company focused on developi...

candel-therapeutics-appoints-charles-schoch-as-cfo-effective-immediately
Candel Therapeutics Appoints Charles Schoc...
06/23/2025 12:06:55

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION